|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Net amortization of securities premiums and discounts and loan fees | |||||
| Decrease (increase) in interest receivable | |||||
| (Decrease) increase in interest payable | |||||
| Provision for credit losses | |||||
| Losses on the sale of debt securities, net | |||||
| Gains on equity securities, net | |||||
| Gains on sale of mortgages | |||||
| Loans originated for sale | |||||
| Proceeds from sales of loans | |||||
| Earnings on bank-owned life insurance | |||||
| Gain on sale of other real estate owned | |||||
| Depreciation of premises and equipment and amortization of software | |||||
| Deferred income tax | |||||
| Amortization of deferred fees on subordinated debt | |||||
| Stock-based compensation expense | |||||
| Other assets and other liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from maturities, calls, and repayments | |||||
| Proceeds from sales | |||||
| Purchases | |||||
| Equity securities: | |||||
| Proceeds from sales | |||||
| Purchases | |||||
| Proceeds from sale of other real estate owned | |||||
| Purchase of regulatory bank stock | |||||
| Redemptions of regulatory bank stock | |||||
| Proceeds from bank-owned life insurance | |||||
| Purchase of bank-owned life insurance | |||||
| Net increase in loans | |||||
| Purchases of premises and equipment, net | |||||
| Purchase of computer software | |||||
| Net cash used for investing activities | |||||
| Cash flows from financing activities: | |||||
| Net increase in demand and savings accounts | |||||
| Net (decrease) increase in time deposits | |||||
| Proceeds (repayments) from short-term borrowings, net | |||||
| Repayments of short-term debt | |||||
| Proceeds from long-term debt | |||||
| Net proceeds from short-term borrowings, net | |||||
| Repayments of long-term debt | |||||
| Proceeds from issuance of subordinated debt | |||||
| Dividends paid | |||||
| Proceeds from issuance of treasury stock | |||||
| Treasury stock purchased | |||||
| Net cash provided by financing activities | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| (Decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Supplemental disclosure of non-cash investing and financing activities: | |||||
| Fair value adjustments for securities available for sale | |||||
| Death benefits receivable on BOLI | |||||
| Recognition of lease operating right-of-use assets | |||||
| Recognition of operating lease liabilities | |||||
| OREO acquired in settlement of loans | |||||
Loading...